Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06094218 · ClinicalTrials.gov registry record · NA
Development of a Treatment Prognosis Calculator for the Prevention of Suicide
A NA study of Suicidal Ideation, sponsored by Ohio State University.
- Recruiting
- Registry status
- NA
- Development phase
- 1,200
- Enrollment target
- 1
- Study location
NCT06094218 is a NA study of Suicidal Ideation that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 1,200 participants, above the 254-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (372% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06094218, a NA study of Suicidal Ideation, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,200 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this interventional study is to develop and test a treatment prognosis calculator to identify which service members with suicidal ideation or behavior are likely to respond well to the current standard of care treatment and which should instead receive Brief Cognitive Behavioral Therapy (BCBT) as a first-line treatment. The main aims of the study are: * Aim 1: To develop a novel treatment prognostic calculator to predict response to treatment as usual (TAU) and identify treatment-seeking military personnel who are unlikely to respond adequately to TAU for the reduction of suicidal ideation. * Aim 2: To evaluate the performance of the treatment prognosis calculator in a new sample of treatment-seeking military personnel and determine whether BCBT is more effective than TAU for those patients who are predicted not to respond adequately to TAU. Participants will receive mental health treatment as it is typically administered by their mental healthcare treatment team. Members of their mental healthcare treatment team may receive intensive training in BCBT. After their provider has received this training, they may use this treatment as part of standard of care treatment. The timing of this training will be determined randomly. Participants will complete self-report assessments at the beginning of the study (baseline) as well as 3, 6, 9 and 12 months after their participant begins. These assessments will include questions about feelings, thoughts, moods, impulses, substance use, and behavior.
Conditions Studied
Interventions
- BEHAVIORAL Treatment as usual (TAU)
- BEHAVIORAL Brief Cognitive Behavioral Therapy (BCBT)
Study Locations (1)
Ohio
- Harding Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2023-10-31 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06094218
The ClinicalTrials.gov registry entry for NCT06094218 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 254-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (372% higher). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Suicidal Ideation appearing as the primary indexed condition, and to 2 interventions - of which Treatment as usual (TAU) is the first listed.
NCT06094218 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06094218 about?
NCT06094218 is a clinical study titled "Development of a Treatment Prognosis Calculator for the Prevention of Suicide". The goal of this interventional study is to develop and test a treatment prognosis calculator to identify which service members with suicidal ideation or behavior are likely to respond well to the current standard of care treatment and which should instead receive Brief Cognitive Behavioral Therapy ...
What is the current status of trial NCT06094218?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,200 participants. The study started on 2023-10-31. Estimated completion is 2027-08-31.
What conditions does trial NCT06094218 study?
This clinical trial studies the following conditions: Suicidal Ideation.
What interventions are being tested in trial NCT06094218?
The interventions under investigation include: Treatment as usual (TAU) (BEHAVIORAL), Brief Cognitive Behavioral Therapy (BCBT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06094218?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06094218 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicidal Ideation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
RECRUITING · NA
-
Inhibitory Mechanisms of Negative Urgency in Adolescent Suicidal Behavior
RECRUITING · NA
-
Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD
RECRUITING · NA
-
Crisis Response Planning for Military Personnel
RECRUITING · NA
-
Suicide Intervention for Alaska Native Youth
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.